Search Orphan Drug Designations and Approvals
-
Generic Name: | L-pyroglutamyl-L-asparaginyl-L-prolyl-D-tyrosyl-D-tryptophan amide |
---|---|
Date Designated: | 01/19/2021 |
Orphan Designation: | Treatment of amyotrophic lateral sclerosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Neuropath Therapeutics Limited 26 Upper Pembroke Street Suite 2006 Dublin 2 Ireland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-